Journal of Korean Neurosurgical Society

  • 제41권1호
  • /
  • Pages.65-68
  • /
  • 2007
  • /
  • 2005-3711(pISSN)
  • /
  • 1598-7876(eISSN)
대한신경외과학회 (The Korean Neurosurgical Society)
권호 표지

Neuropathic Back Pain : Are There Any Practical Diagnostic Criteria?

  • Lee, Kyeong-Seok (Department of Neurosurgery, Soonchunhyang University Cheonan Hospital) ;
  • Shim, Jae-Jun (Department of Neurosurgery, Soonchunhyang University Cheonan Hospital) ;
  • Doh, Jae-Won (Department of Neurosurgery, Soonchunhyang University Cheonan Hospital) ;
  • Yoon, Seok-Mann (Department of Neurosurgery, Soonchunhyang University Cheonan Hospital) ;
  • Bae, Hack-Gun (Department of Neurosurgery, Soonchunhyang University Cheonan Hospital) ;
  • Yun, Il-Gyu (Department of Neurosurgery, Soonchunhyang University Cheonan Hospital)
  • 발행 : 2007.01.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective : A new point of view on the chronic back pain proposed which is, named neuropathic back pain[NBP]. Some proposed a certain pain scale as an useful diagnostic tool. Before scientific verification, some doctors prescribed a new anticonvulsant for the NBP. We investigated diagnostic tools for NBP by a review of the literature. Methods : A comprehensive computer search of the English literature concerning neuropathic low back pain was performed using the key words such as neuropathic back pain and diagnosis in the PubMed. Results : In 1998, the term NBP was first used in a patient with lung cancer. In the English literature, there were two diagnostic methods for the NBP, Neuropathic pain scale[NPS] and a pharmacological test. NPS is a pain questionnaire, which depends on the patients' subjective reports on the given questions, such as 'how hot is your pain feel'. By the pharmacological test, NBP was defined as 50% or more decrease of pain on intravenous lidocaine and on local anesthetic epidurally. It also depends on the patients' subjective response to the therapy. Conclusion : There were still no reliable objective diagnostic criteria for the NBP. It seems to be better to reserve the new anticonvulsants for the NBP till scientific approval.

키워드

참고문헌

  1. Adams C, Young A : Violating the Promise to 'Do No Harm'. [monograph on the internet]. Milwaukee Journal Sentinel; 2004 [cited 2005 Jul 15]. Available from: http://www.crossroadsinstitute.orglnewsletter/june04.html
  2. Adams MA : Biomechanics of back pain. Acupunct Med 22 : 178-188, 2004 https://doi.org/10.1136/aim.22.4.178
  3. Argoff CE : Conclusions: chronic pain studies of lidocaine patch 5% using the Neuropathic Pain Scale. Curr Moo Res Opin 20: S29-31, 2004 https://doi.org/10.1185/030079904X12979
  4. Argoff CE, Galer BS, Jensen MP, Oleka N, Gammaitoni AR: Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale. Curr Med Res Opin 20: S21-28, 2004 https://doi.org/10.1185/030079904X12960
  5. Bennett M : The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 92: 147-157, 2001 https://doi.org/10.1016/S0304-3959(00)00482-6
  6. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al : Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114: 29-36, 2005 https://doi.org/10.1016/j.pain.2004.12.010
  7. Bouhassira D, Anal N, Fermanian J, Alchaat H, Gautron M, Masquelier E, et al : Development and validation of the Neuropathic Pain Symptom Inventory. Pain 108: 248-257, 2004 https://doi.org/10.1016/j.pain.2003.12.024
  8. Braverman DL, Slipman CW, Lenrow DA : Using gabapentin to treat faited back surgery syndrome caused by epidural fibrosis: A report of 2 cases. Arch Phys Med Rehabil 82: 691-693, 2001 https://doi.org/10.1053/apmr.2001.21867
  9. Carragee EJ, Hannibal M : Diagnostic evaluation of low back pain. Orthop Clin North Am 35: 7-16, 2004 https://doi.org/10.1016/S0030-5898(03)00099-3
  10. Chung JM, Chung K: Sodium channels and neuropathic pain. Novartis Found Syrup 261 : 19-27, 2004 https://doi.org/10.1002/0470869127.ch3
  11. Deyo RA, Rainville J, Kent DL: What can the history and physical examination tell us about low back pain? JAMA 268: 760-765, 1992 https://doi.org/10.1001/jama.268.6.760
  12. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, et al : Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60 : 1524-1534, 2003 https://doi.org/10.1001/archneur.60.11.1524
  13. Flor H : Cortical reorganisation and chronic pain: implications for rehabilitation. J Rehabil Med 41 : 566-72, 2003
  14. Galer BS, Gammaitoni AR, Oleb N, Jensen MP, Argoff CE: Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain. Curr Med Res Opin 20 : S5-12, 2004
  15. Grabois M : Management of chronic low back pain. Am J Phys Med Rehabil 84 : 529-41, 2005
  16. Hadler NM, Greenhalgh S : Labeling woefulness: the social construction of fibromyalgia. Spine 30 : 1-4, 2005 https://doi.org/10.1097/00007632-200511010-00031
  17. Hansson P : Neuropathic pain : clinical characteristics and diagnostic workup. Eur J Pain 6: 47-50, 2002 https://doi.org/10.1053/eujp.2001.0322
  18. Hassan AE, Saleh HA, Baroudy YM, Abdul-Rahman KI, Najjar MW, Kazi MS, et al : Prevalence of neuropathic pain among patients suffering from chronic low back pain in Saudi Arabia. Saudi Med J 25 : 19861990, 2004
  19. IASP Task Force on Taxonomy: IASP Pain Terminology in Merskey H, Bogduk N(eds) : Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms, ed 2. Seattle: IASP Press, 1994, pp209- 214
  20. Jensen MP : Introducrion : chronic pain studies of the lidocaine patch 5% using the Neuropathic Pain Scale. Curr Med Res Opin 20: 51-4, 2004
  21. Jensen MP, Dworkin RH, Gammaitoni AR, Olaleye DO, Oleka N, Galer BS : Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. J Pain 6 : 98-106, 2005 https://doi.org/10.1016/j.jpain.2004.11.002
  22. Jensen TS, Gottrup H, Sindrup SH, Bach FW: The clinical picture of neuropathic pain. Eur J Pharmacal 429 : 1-11, 2001 https://doi.org/10.1016/S0014-2999(01)01302-4
  23. Ji RR, Woolf CJ : Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis 8 : 1-10, 2001 https://doi.org/10.1006/nbdi.2000.0360
  24. Krause SJ, Backonja MM : Development of a neuropathic pain questionnaire. Clin J Pain 19: 306-314, 2003 https://doi.org/10.1097/00002508-200309000-00004
  25. Marchand F, Perretti M, McMahon SB : Role of the immune system in chronic pain. Nat Rev Neurosci 6: 521-532, 2005
  26. Market-Research-Report.corn [homepage on the internet] : Neuropathic Low Back Pain - Off-label Revenue Despite Diagnostic Challenge. [cited 2005 Jul 15]. Available from: http://www.market-researchreport. com/datamonitoriDMHC2013.htm
  27. McMahon SB, Cafferty WB, Marchand F : Immune and glial cell factors as pain mediators and modulators. Exp Neurol 192 : 444-462, 2005 https://doi.org/10.1016/j.expneurol.2004.11.001
  28. Moskowitz MH : Pharmacotherapy of neuropathic low back pain. Curr Pain Headache Rep 7 : 178-187, 2003 https://doi.org/10.1007/s11916-003-0071-8
  29. Nicholson BD : Diagnosis and management of neuropathic pain: a balanced approach to treatment. J Am Acad Nurse Pract 15: S3-9, 2003 https://doi.org/10.1111/j.1745-7599.2003.tb00247.x
  30. Online-lawyer-source. com [homepage on the internet] : Pfizer Sued Again Over Improper Marketing of Neurontin. [cited 2005 Jul 15]. Available from: http://www.onlinelawyersource.com/news/pfizersued.html
  31. Rives PA, Douglass AB : Evaluation and treatment of low back pain in family practice. J Am Board Fam Pract 17 : 523-31, 2004
  32. Roos DE : Neuropathic back pain: discordance between the level of the involved spine/rib and the associated dermatome. Clin Oneal (R Call Radial) 10: 337-338, 1998 https://doi.org/10.1016/S0936-6555(98)80094-0
  33. Roos DE, Turner SL, O'Brien PC, Smith JG, Spry NA, Burmeister BH, et al : Randomized trial of 8 Gy in 1 versus 20Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metasrases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 75 : 54-63, 2005 https://doi.org/10.1016/j.radonc.2004.09.017
  34. Rosenberg JM, Harrell C, Ristic H, Wernet RA, de Rosayro AM: The effect of gabapentin on neuropathic pain. Clin J Pain 13 : 251-255, 1997 https://doi.org/10.1097/00002508-199709000-00011
  35. Rosner H, Rubin L, Kestenbaum A: Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain 12 : 56-58, 1996 https://doi.org/10.1097/00002508-199603000-00010
  36. Schwartzman RJ, Grothusen J, Kiefer TR, Rohr P : Neuropathic central pain; epidemiology, etiology, and treatment options. Arch Neurol 58 : 1547-1550, 2001 https://doi.org/10.1001/archneur.58.10.1547
  37. Segal AZ, Rordorf G : Gabapenrin as a novel treatment for postherpetic neuralgia. Neurology 46 : 1175-1176, 1996 https://doi.org/10.1212/WNL.46.4.1175
  38. Sist TC, Filadora VA 2nd, Miner M, Lema M : Experience with gabapenrin for neuropathic pain in the head and neck: report of ten cases. Reg Anesth 22: 473-478, 1997 https://doi.org/10.1016/S1098-7339(97)80037-5
  39. Sorensen J, Aaro S, Bengtsson M, Kalman S, Reigo T, Tropp H : Can a pharmacological pain analysis in patienrs with chronic low back pain predict the outcome of lumbar fusion? Preliminary report. Eur Spine J 5 : 326-331,1996 https://doi.org/10.1007/BF00304348
  40. Sorensen J, Kalman S, Tropp H, Bengtsson M : Can a pharmacological pain analysis be used in the assessment of chronic low back pain? Eur Spine J 5: 236-242, 1996 https://doi.org/10.1007/BF00301326
  41. Sumpton JE, Moulin DE : Treatment of neuropathic pain with venlafaxine. Ann Pharrnacother 35: 557-559, 2001 https://doi.org/10.1345/aph.10206
  42. van Tulder M, Koes B, Bombardier C: Low back pain. Best Pract Res Clin Rheumatol 16: 761-775, 2002 https://doi.org/10.1053/berh.2002.0267
  43. Watkins LR, Maier SF, Goehler LE : Immune activation: the role of pro-inflammatory cyrokines in inflammation, illness responses and pathological pain states. Pain 63 : 289-302, 1995 https://doi.org/10.1016/0304-3959(95)00186-7
  44. Wetzel CH, Connelly JF : Use of gabapentin in pain management. Ann Pharmacother 31 : 1082-1083, 1997 https://doi.org/10.1177/106002809703100920
  45. Woolf CJ : The pathophysiology of peripheral neuropathic pain-abnormal peripheral input and abnormal central processing. Acta Neurochir (Wien) Suppl 58 : 125-130, 1993
  46. Yoon YS, Back SK, Kim HJ, Na HS ; Neuropathic Pain Behaviors and the Change of Spinal Neuropeptides following Peripheral Nerve Injury in Neonatal Rats. J Korean Neurosurg Soc 39: 52-57, 2006
  47. Zieglgansberger W, Berthele A, Tolle TR: Understanding neuropathic pain. CNS Spectr 10 : 298-308, 2005 https://doi.org/10.1017/S1092852900022628